Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: Germany,Spain,Australia,South Africa,France,Hungary,Czech Republic,Austria,United Kingdom,Italy - Le promoteur: Professor
Professor
MAJ Il y a 5 ans
A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
This is a phase III multi-centre study in three periods: the first period is a phosphate binder washout for 4 weeks, the second period is an open-label, randomised, parallel group, flexible dose, the third period is a placebo-controlled withdrawal comparing MCI-196 with placebo for 4 weeks.
Pays
Australia
,
Austria
,
Czech Republic
,
France
,
Germany
,
Hungary
,
Italy
,
Poland
,
South Africa
,
Spain
,
United Kingdom
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
1